References
- Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Mov Disord 2007;22:279-282 https://doi.org/10.1002/mds.21282
- Zesiewicz TA, Encarnacion E, Hauser RA. Management of essential tremor. Curr Neurol Neurosci Rep 2002;2:324-330 https://doi.org/10.1007/s11910-002-0008-3
- Jankovic J. Essential tremor: a heterogenous disorder. Mov Disord 2002;17:638-644 https://doi.org/10.1002/mds.10221
- Song IU, Kim JS, Lee SB, Ryu SY, An JY, Kim HT, et al. Effects of zonisamide on isolated head tremor. Eur J Neurol 2008;15:1212-1215 https://doi.org/10.1111/j.1468-1331.2008.02296.x
- Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 2002;333:17-20 https://doi.org/10.1016/S0304-3940(02)00966-7
- Quattrone A, Cerasa A, Messina D, Nicoletti G, Hagberg GE, Lemieux L, et al. Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. AJNR Am J Neuroradiol 2008;29:1692-1697 https://doi.org/10.3174/ajnr.A1190
- Jankovic J. Essential tremor: clinical characteristics. Neurology 2000;54(11 Suppl 4):S21-S25
- Groenewegen HJ. The basal ganglia and motor control. Neural Plast 2003;10:107-120 https://doi.org/10.1155/NP.2003.107
- Gerfen CR. Molecular effects of dopamine on striatalprojection pathways. Trends Neurosci 2000;23(10 Suppl):S64-S70 https://doi.org/10.1016/S1471-1931(00)00019-7
- Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000;23(10 Suppl):S71-S77 https://doi.org/10.1016/S1471-1931(00)00027-6
Cited by
- Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? vol.139, pp.11, 2016, https://doi.org/10.1093/brain/aww223
- Essential Tremor: What We Can Learn from Current Pharmacotherapy vol.6, pp.None, 2016, https://doi.org/10.7916/d8k35tc3
- Structural differences in impaired verbal fluency in essential tremor patients compared to healthy controls vol.7, pp.7, 2015, https://doi.org/10.1002/brb3.722
- General and selective brain connectivity alterations in essential tremor: A resting state fMRI study vol.16, pp.None, 2015, https://doi.org/10.1016/j.nicl.2017.06.004
- A Voxel-Wise Meta-Analysis of Gray Matter Abnormalities in Essential Tremor vol.9, pp.None, 2015, https://doi.org/10.3389/fneur.2018.00495
- Metabolic Positron Emission Tomography Response to Gamma Knife of the Ventral Intermediate Nucleus in Essential Tremor vol.84, pp.6, 2015, https://doi.org/10.1093/neuros/nyy340
- Current and Future Neuropharmacological Options for the Treatment of Essential Tremor vol.18, pp.6, 2015, https://doi.org/10.2174/1570159x18666200124145743
- The Molecular Neuroimaging of Tremor vol.21, pp.12, 2015, https://doi.org/10.1007/s11910-021-01157-4
- The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models vol.11, pp.12, 2021, https://doi.org/10.3390/biom11121813